tiprankstipranks
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
US Market
Holding PBSV?
Track your performance easily

Pharma Bio Services (PBSV) Stock Price & Analysis

41 Followers

PBSV Stock Chart & Stats


Financials

Annual

Ownership Overview

11.29%88.71%
11.29% Insiders
― Other Institutional Investors
88.71% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

PBSV FAQ

What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.31 and its highest was $1.09 in the past 12 months.
    What is Pharma Bio Services’s market cap?
    Currently, no data Available
    When is Pharma Bio Services’s upcoming earnings report date?
    Pharma Bio Services’s upcoming earnings report date is Sep 12, 2024 which is 90 days ago.
      How were Pharma Bio Services’s earnings last quarter?
      Pharma Bio Services released its earnings results on Jun 12, 2024. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.04.
        Is Pharma Bio Services overvalued?
        According to Wall Street analysts Pharma Bio Services’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Pharma Bio Services pay dividends?
          Pharma Bio Services pays a Annually dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Services dividends here
            What is Pharma Bio Services’s EPS estimate?
            Pharma Bio Services’s EPS estimate is $0.03.
              How many shares outstanding does Pharma Bio Services have?
              Pharma Bio Services has 22,958,143 shares outstanding.
                What happened to Pharma Bio Services’s price movement after its last earnings report?
                Pharma Bio Services reported an EPS of -$0.01 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Pharma Bio Services?
                  Currently, no hedge funds are holding shares in PBSV
                  ---

                  Pharma Bio Services Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -44.95%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -5.63%
                  Trailing 12-Months
                  Asset Growth
                  -19.60%
                  Trailing 12-Months

                  Company Description

                  Pharma Bio Services

                  Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device and biotechnology industries. It operates through the following business segments: Puerto Rico Technical Compliance Consulting; United States Technical Compliance Consulting; Europe Technical Compliance Consulting. The company was founded on January 14, 2004 and is headquartered in Dorado, Puerto Rico.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cyclacel Pharmaceuticals
                  Cardiff Oncology
                  Genprex
                  Lipocine
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis